Research Article
Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists
| | CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ICH |
| | Length of stay, (days, range) | 7 (1-38) |
| | SBP on admission (mmHg, range) | 160 (110-242) |
| | DBP on admission (mmHg, range) | 81.5 (40-146) |
| | HR on admission (bpm, range) | 79 (41-150) |
| | Glycemia on admission (mg/dl, range) | 137 (76-280) |
| | ICH volume (cm) | 23.7 (mean=15) |
| | Baseline NIHSS | 13 (0-42) |
| | NIHSS at discharge | 16 (0-42) |
| | NIHSS at discharge (survivors) | 2 (0-16) |
| | Structural lesion | | | (i) None | 51 (96%) | | (ii) Cavernoma N (%) | 2 (4%) |
| | In-hospital mortality N (%) | 27 (51%) |
| | 3-month mortality N (%) | 29 (64.4%) |
| | Intraventricular extension N (%) | 20 (38.4%) |
| | Seizures N (%) | 2 (4%) |
| | Clinical worsening N (%) | 27 (61.4%) |
| | Repetition of imaging studies N (%) | 22 (50%) |
| | Haematoma expansion N (%) | 13 (59%) |
| | Withdrawal of care N (%) | 11 (25%) |
| | mRS after 3 months N (%) | | | (i) 0-3 | 13 (29%) | | (ii) 4-6 | 40 (71%) |
| | Haemorrhage location N (%) | | | (i) Deep | 20 (38%) | | (ii) Lobar | 15 (29%) | | (iii) Intraparenchymal extensive | 9 (17%) | | (iv) Intraventricular | 1 (2%) | | (v) Brainstem | 6 (11.5%) | | (vi) Cerebellum | 2 (4%) |
|
|
ICH: intracranial haemorrhage. SBP: systolic blood pressure. DBP: diastolic blood pressure. HR: heart rate. NIHSS: National Institutes of Health Stroke Scale. mRS: Modified Rankin Scale. Values are shown as median (range) unless otherwise specified.
|
